You searched for Antibody candidate - Page 11 of 69

In Depth 28 May 2025

New weight loss drugs: Biotech’s mission to end obesity

…Viking’s candidate appeared to have “outmaneuvered” amycretin. Biopharma giant Amgen is also seeing positive results for its most advanced obesity asset MariTide, a monoclonal antibody linked to a pair of…

May 28, 2025 - 17 minutesmins - By Willow Shah-Neville

cancer cell screening drug discovery microplate

News and Trends 7 Oct 2022

GATC AI platform reduces time to find opioid use disorder candidates

…candidates’ safety and efficacy in reducing opioid consumption, withdrawal symptoms and relapse. To discover these specific drug candidates for OUD, GATC obtained addiction drug target biomarkers from Liquid Biosciences, an…

October 7, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 13 Jun 2024

Eight companies tackling cancer with allogeneic cell therapy in 2024

…candidates are engineered T cells designed to express the Tmod receptors, enabling them to differentiate between cancerous and non-cancerous cells. This selective targeting aims to reduce off-target effects and improve…

June 13, 2024 - 9 minutesmins - By Jules Adam

Best in Biotech 11 Apr 2024

Seven companies leading the mRNA revolution in biotechnology

…2 results from last week revealed that the seasonal flu vaccine candidate boosted antibody titers at all dose levels and for all encoded seasonal influenza strains across younger and older…

April 11, 2024 - 8 minutesmins - By Roohi Mariam Peter

Best in Biotech 28 Mar 2024

Are these T cell receptor (TCR) therapy companies on your radar?

…and allogeneic candidates as well as antibody-like TCR bispecifics, called T cell Engaging Receptors (TCER). TCERs are biologics that are designed to bind T cells to target and destroy cancer…

March 28, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 24 Mar 2016

Novel Antibody for Influenza gets FDA Fast-Track Approval

Humabs (Switzerland) has gotten some serious recognition for its antibody platform, as its candidates for Influenza have received FDA fast-track designation. A biologic therapy for Influenza A has been granted…

March 24, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 8 Nov 2017

Phase I Results are in for Swedish Biotech’s Cancer Antibody

…develops antibody-based immunotherapies to fight cancer. Its pipeline includes clinical and pre-clinical drug candidates, including ADC-1013 and ATOR-1015, as well as novel research candidates. The company has announced that its…

November 8, 2017 - 3 minutesmins - By Alex Dale

News and Trends 20 Dec 2019

CureVac and Genmab Team up to Make Antibody Cancer Drugs out of RNA

…could be circumvented by delivering simple mRNA blueprints for antibody drugs into the patient, and turning the patient’s own cells into antibody factories. There are challenges to overcome on the…

December 20, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 4 Nov 2024

Top biotech deals of October 2024

…arteries restricts blood supply to leg muscles. While financial terms weren’t revealed, the candidate they plan to advance was disclosed. ISM-001 is an antibody designed to neutralize an antibody that…

November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 12 Dec 2024

Top biotech deals of November 2024

…part of this wintry time. Moreover, biotech deals in antibody-drug conjugates, small molecules, antibody therapies, GLP-1 agonists, and precision medicine stood out in November 2024. Table of contents Top M&As…

December 12, 2024 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 6 Mar 2025

Top biotech deals of February 2025

…$2.15 billion in milestone payments, with Novartis having paid $925 million upfront. Anthos will hand over its monoclonal antibody program, which is in the clinic to prevent stroke and systemic…

March 6, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 26 Oct 2016

Can this new Antibody-Drug Conjugate Collaboration make it to the Top?

Nordic Nanovector is collaborating with Heidelberg Pharma to access the promising antibody-drug conjugate (ADC) technology. However, can it really take on the strong competition? Nordic Nanovector develops antibody-radionuclide conjugates (ARCs)…

October 26, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

New weight loss drugs: Biotech’s mission to end obesity

GATC AI platform reduces time to find opioid use disorder candidates

Eight companies tackling cancer with allogeneic cell therapy in 2024

Seven companies leading the mRNA revolution in biotechnology

Are these T cell receptor (TCR) therapy companies on your radar?

Novel Antibody for Influenza gets FDA Fast-Track Approval

Phase I Results are in for Swedish Biotech’s Cancer Antibody

CureVac and Genmab Team up to Make Antibody Cancer Drugs out of RNA

Top biotech deals of October 2024

Top biotech deals of November 2024

Top biotech deals of February 2025

Can this new Antibody-Drug Conjugate Collaboration make it to the Top?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!